查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1460146

脑电图系统市场 - 按产品、类型、应用、最终用途 - 全球预测，2024 年 - 2032 年

Electroencephalograph Systems Market - By Product, Type, Application, End-use - Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 201 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在神经系统疾病盛行率上升和技术不断进步的推动下，脑电图系统市场预计在 2024 年至 2032 年间以 6.4% 的CAGR成长。随着越来越多的人受到癫痫、阿兹海默症和帕金森氏症等疾病的影响，对脑电图 (EEG) 系统等准确诊断工具的需求不断增加。无线连接、可携式设备和先进的讯号处理演算法等技术创新有助于提高脑电图系统的效率和精确度，使其在神经系统疾病的诊断和监测中不可或缺。

2024 年 2 月，Neurotechnology 升级了 BrainAccess 套件，提供完整的干接触脑电图解决方案，包括头饰、电极、脑电图仪、脑电图资料收集和视觉化软体，以及用于设定脑电图实验的通用基础设施。尖端技术的不断发展和产品接受度的不断提高将促进市场成长。

脑电图系统产业分为产品、类型、应用、最终用途和区域。

根据产品，多通道细分市场的市场规模预计在 2024 年至 2032 年间将以 6.6% 的CAGR增长。多通道脑电图系统提供增强的能力，以更高的精度和细节监测大脑活动，以满足不同的临床和研究需求。这些系统能够同时记录多个大脑区域，从而提供对神经系统疾病、睡眠模式和认知功能的全面见解。神经系统疾病的盛行率不断上升，加上神经科学研究活动的不断增加，推动了对先进多通道脑电图系统的需求。此外，提供即时资料分析、可自订电极配置和动态监测位置的便携性的强大能力将进一步促进该细分市场的成长。

在应用方面，预计到 2032 年，睡眠障碍领域的脑电图系统市场CAGR将达到6.3%。脑电图系统已成为诊断和监测睡眠障碍（如失眠、睡眠呼吸中止症和异态睡眠）的重要解决方案。它们也为不同睡眠阶段的睡眠模式、脑电波活动和异常提供了宝贵的见解。由于生活方式的改变和人口老化，全球睡眠障碍盛行率不断上升，对先进脑电图技术的需求可能会大幅激增。

鑑于区域格局，在医疗保健支出增加、对神经系统疾病的认识不断提高以及研发活动不断扩大的推动下，亚太地区脑电图系统产业将在 2024 年至 2032 年间呈现强劲成长。由于神经系统疾病、睡眠相关疾病的日益普及以及对准确诊断工具的需求，中国、印度、日本和韩国对脑电图系统的需求激增。例如，2023 年 8 月，杨潞龄医学院、睡眠与认知中心的研究人员与 Oura Health 合作发现，亚洲人的睡眠品质比欧洲和北美人的睡眠品质更差。医疗基础设施的强劲进步、老年人口的增加以及政府倡议将进一步增强该地区的行业前景。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 神经系统疾病的发生率不断上升
      • 神经科学研究的增加
      • 技术进步与产品创新
      • 意识和医疗基础设施不断提高
    • 产业陷阱与挑战
      • 脑电图设备成本高
      • 解释和标准化方面的挑战
  • 成长潜力分析
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

  • 主要趋势
  • 8通道脑电图
  • 21通道脑电图
  • 25通道脑电图
  • 32通道脑电图
  • 40通道脑电图
  • 多通道脑电图

第 6 章：市场估计与预测：按类型，2018 - 2032

  • 主要趋势
  • 便携式设备
  • 独立设备

第 7 章：市场估计与预测：按应用划分，2018 年 - 2032 年

  • 主要趋势
  • 癫痫
  • 睡眠障碍
  • 脑肿瘤和病变
  • 中风
  • 精神疾病
  • 脑图谱
  • 其他应用

第 8 章：市场估计与预测：按最终用途，2018 - 2032 年

  • 主要趋势
  • 医院
  • 神经病学中心
  • 诊断中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • Bio-Logic Systems Corporation
  • BrainScope Company, Inc.
  • Cadwell Industries, Inc.
  • Compumedic Neuroscan
  • Compumedics Limited
  • EBNeuro S.p.A.
  • Elekta AB
  • Interaxon Inc.
  • Medtronic plc
  • Natus Medical Incorporated
  • NeuroWave Systems Inc.
简介目录
Product Code: 3927

Electroencephalograph Systems Market is poised to expand at 6.4% CAGR between 2024 and 2032 driven by the rising prevalence of neurological disorders and the continuous technological advancements. With an increasing number of individuals affected by conditions, such as epilepsy, Alzheimer's, and Parkinson's diseases, there is a heightened demand for accurate diagnostic tools like electroencephalograph (EEG) systems. Technological innovations, such as wireless connectivity, portable devices, and advanced signal processing algorithms help enhance the efficiency and precision of EEG systems, making them indispensable in the diagnosis and monitoring of neurological conditions.

In February 2024, Neurotechnology upgraded its BrainAccess kits to provide a complete dry-contact electroencephalography solution comprising headwear, electrodes, an electroencephalograph, and software for EEG data collection and visualization, along with general infrastructure for setting up EEG experiments. This rising development of cutting-edge technologies and the product surging acceptance will add to the market growth.

The EEG systems industry is segmented into product, type, application, end-use, and region.

Based on product, the market size from the multi-channel segment is projected to accrue 6.6% CAGR between 2024 and 2032. Multi-channel EEG systems offer enhanced capabilities in monitoring brain activity with higher precision and detail for catering to diverse clinical and research needs. These systems enable simultaneous recording from multiple brain regions for providing comprehensive insights into neurological disorders, sleep patterns, and cognitive functions. The rising prevalence of neurological diseases, coupled with increasing research activities in neuroscience is fueling the demand for advanced multi-channel EEG systems. Additionally, the strong ability to offer real-time data analysis, customizable electrode configurations, and portability for ambulatory monitoring positions will further contribute to the segment growth.

In terms of application, the electroencephalograph systems market from the sleep disorders segment is anticipated to witness 6.3% CAGR through 2032. EEG systems have emerged as essential solutions for diagnosing and monitoring sleep disorders, such as insomnia, sleep apnea, and parasomnias. They also provide invaluable insights into sleep patterns, brain wave activities, and abnormalities during different sleep stages. With the rising global prevalence of sleep disorders due to lifestyle changes and aging populations, the demand for advanced EEG technologies is likely to significantly surge.

Given the regional landscape, the Asia Pacific electroencephalograph systems industry is set to exhibit robust growth between 2024 and 2032 fueled by the increasing healthcare expenditure, rising awareness about neurological disorders, and expanding R&D activities. China, India, Japan, and South Korea are witnessing a surge in demand for EEG systems due to the growing prevalence of neurological conditions, sleep-related disorders, and the need for accurate diagnostic tools. For instance, in August 2023, researchers from the Yong Loo Lin School of Medicine along with the Centre for Sleep and Cognition in collaboration with Oura Health, discovered that Asians report worse sleep than people living in Europe and North America. Strong advancements in healthcare infrastructure, the rising geriatric population, and government initiatives will further augment the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing incidence of neurological disorders
      • 3.2.1.2 Increased research in neuroscience
      • 3.2.1.3 Technological advancements and product innovations
      • 3.2.1.4 Rising awareness and healthcare infrastructure
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of EEG equipment
      • 3.2.2.2 Challenges in interpretation and standardization
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 8-channel EEG
  • 5.3 21-channel EEG
  • 5.4 25-channel EEG
  • 5.5 32-channel EEG
  • 5.6 40-channel EEG
  • 5.7 Multi-channel EEG

Chapter 6 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Portable device
  • 6.3 Standalone device

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Epilepsy
  • 7.3 Sleep disorders
  • 7.4 Brain tumours and lesions
  • 7.5 Stroke
  • 7.6 Psychiatric disorders
  • 7.7 Brain mapping
  • 7.8 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Neurology centers
  • 8.4 Diagnostic centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Bio-Logic Systems Corporation
  • 10.2 BrainScope Company, Inc.
  • 10.3 Cadwell Industries, Inc.
  • 10.4 Compumedic Neuroscan
  • 10.5 Compumedics Limited
  • 10.6 EBNeuro S.p.A.
  • 10.7 Elekta AB
  • 10.8 Interaxon Inc.
  • 10.9 Medtronic plc
  • 10.10 Natus Medical Incorporated
  • 10.11 NeuroWave Systems Inc.